FDA Inspection 1230113 - EyePoint Pharmaceuticals, Inc. - February 15, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns EyePoint Pharmaceuticals, Inc., with an inspection on February 15, 2024, issued by the New England District Office, covering human drugs.

Company: EyePoint Pharmaceuticals, Inc.
Inspection Date: February 15, 2024
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · 96011f71-7dc7-4d1e-af2a-8fb571d5f403

Violation Codes7

21 CFR 211.100(b)21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.186(a)21 CFR 211.19221 CFR 211.42(c)(10)(v)21 CFR 211.67(a)

Full citation text and observation details available on the Dashboard.